Novo Nordisk's obesity drug CagriSema failed to outperform Eli Lilly's Mounjaro in the latest trial, causing a dip in Novo's ...

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...

An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as ...

Novo Nordisk stock slumps as the 15.7% weight loss achieved with its next-gen obesity candidate, CagriSema, in the second ...

Better-than-expected price data can’t quite blunt worries about consumers pulling back, as companies keep scrambling to ...

European shares experienced gains driven mainly by healthcare stocks, despite fears of an escalating U.S.-EU trade war. The ...

AirSculpt Technologies, Inc. (NASDAQ: AIRS) Q4 2024 Earnings Call Transcript March 14, 2025 AirSculpt Technologies, Inc.

Cynthia is an independent bilingual magazine focusing on the world of música Mexicana that's geared for Gen Z.

Ahead of his largest-ever exhibition in the U.S., the dissident artist reflects on collecting jade and living below ground.

Adults with obesity and type 2 diabetes receiving once-weekly combination cagrilintide 2.4 mg and semaglutide 2.4 mg lost ...

People with intermediate-risk scores on coronary artery calcium testing who received statins and intensive health coaching ...

The US Food and Drug Administration (FDA) has cleared Miach Orthopaedics Bridge-Enhanced ACL Restoration (BEAR) implant for ...